Epstein-Barr virus infection in immortalized nasopharyngeal epithelial cells: Regulation of infection and phenotypic characterization

International Journal of Cancer

Volumn 127, Issue 7, 2010, Pages 1570-1583

  Tsang, Chi Man ^a   Zhang, Guitao ^a   Seto, Eri ^b   Takada, Kenzo ^b   Deng, Wen ^a   Yip, Yim Ling ^a   Man, Cornelia ^a   Hau, Pok Man ^a   Chen, Honglin ^a   Cao, Ya ^c   Lo, Kwok Wai ^d   Middeldorp, Jaap M ^e   Cheung, Annie Lai Man ^a   Tsao, Sai Wah ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b HOKKAIDO UNIVERSITY   (Japan)

^c Central South University   (China)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Esptein Barr virus; Nasopharyngeal epithelial carcinoma; Premalignant nasopharyngeal epithelium

Indexed keywords

CYTOKINE; GROWTH FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN KINASE B; TELOMERASE; TRANSFORMING GROWTH FACTOR BETA; CHEMOKINE RECEPTOR CCR2; COMPLEMENT COMPONENT C3D RECEPTOR; PRIMER DNA;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL IMMORTALIZATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; EPITHELIUM CELL; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; GENE EXPRESSION; INFECTION CONTROL; INFECTION RATE; MOUSE; NASOPHARYNGEAL EPITHELIAL CELL; NONHUMAN; NUTRIENT; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STARVATION; UPREGULATION; ANIMAL; CELL LINE; CHROMOSOME MAP; GENE EXPRESSION PROFILING; GENETICS; HUMAN; ISOLATION AND PURIFICATION; KARYOTYPING; METABOLISM; NASOPHARYNX; NASOPHARYNX TUMOR; NUDE MOUSE; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIROLOGY;

ANIMALS; CELL LINE; CHROMOSOME MAPPING; DNA PRIMERS; EPITHELIAL CELLS; EPSTEIN-BARR VIRUS INFECTIONS; GENE EXPRESSION PROFILING; HERPESVIRUS 4, HUMAN; HUMANS; KARYOTYPING; MICE; MICE, NUDE; NASOPHARYNGEAL NEOPLASMS; NASOPHARYNX; PHENOTYPE; RECEPTORS, CCR2; RECEPTORS, COMPLEMENT 3D; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77956601893     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25173     Document Type: Article

References (31)

1. Israel BF, Kenney SC. Virally targeted therapies for EBV-associated malignancies. Oncogene 2003;22:5122-30.
2. Dolcetti R, Masucci MG. Epstein-Barr virus: induction and control of cell transformation. J Cell Physiol 2003;196:207-18.
3. Murray PG, Young LS. Epstein-Barr virus infection: basis of malignancy and potential for therapy. Expert RevMol Med 2001;3:1-20.
4. Thompson MP, Kurzrock R. Epstein-Barr virus and cancer. Clin Cancer Res 2004;10:803-21.
5. Raab-Traub N. Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol 2002;12:431-41.
6. Chang Y, Tung CH, Huang YT, Lu J, Chen JY, Tsai CH. Requirement for cell-to-cell contact in Epstein-Barr virus infection of nasopharyngeal carcinoma cells and keratinocytes. J Virol 1999;73:8857-66.
7. Shannon-Lowe CD, Neuhierl B, Baldwin G, Rickinson AB, Delecluse HJ. Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells. Proc Natl Acad Sci USA 2006;103:7065-70.
8. Tugizov SM, Berline JW, Palefsky JM. Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells. Nat Med 2003;9:307-14.
9. Li HM, Man C, Jin Y, Deng W, Yip YL, Feng HC, Cheung YC, Lo KW, Meltzer PS, Wu ZG, Kwong YL, Yuen AP et al. Molecular and cytogenetic changes involved in the immortalization of nasopharyngeal epithelial cells by telomerase. Int J Cancer 2006;119:1567-76.
10. Lo KW, To KF, Huang DP. Focus on nasopharyngeal carcinoma. Cancer Cell 2004;5:423-8.
11. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-7.
12. Lo AK, Lo KW, Tsao SW, Wong HL, Hui JW, To KF, Hayward DS, Chui YL, Lau YL, Takada K, Huang DP. Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells. Neoplasia 2006;8:173-80.
13. Imai S, Nishikawa J, Takada K. Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J Virol 1998;72:4371-8.
14. Li HM, Zhuang ZH, Wang Q, Pang JC, Wang XH, Wong HL, Feng HC, Jin DY, Ling MT, Wong YC, Eliopoulos AG, Young LS et al. Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells. Oncogene 2004;23:4488-94.
15. Lu J, Chua HH, Chen SY, Chen JY, Tsai CH. Regulation of matrix metalloproteinase-1 by Epstein-Barr virus proteins. Cancer Res 2003;63:256-62.
16. Deng W, Tsao SW, Lucas JN, Leung CS, Cheung AL. A new method for improving metaphase chromosome spreading. Cytometry A 2003;51:46-51.
17. Feederle R, Neuhierl B, Bannert H, Geletneky K, Shannon-Lowe C, Delecluse HJ. Epstein-Barr virus B95.8 produced in 293 cells shows marked tropism for differentiated primary epithelial cells and reveals interindividual variation in susceptibility to viral infection. Int J Cancer 2007;121:588-94.
18. Pegtel DM, Middeldorp J, Thorley-Lawson DA. Epstein-Barr virus infection in ex vivo tonsil epithelial cell cultures of asymptomatic carriers. J Virol 2004;78:12613-24. (Pubitemid 39458779)
19. Nizet V, Johnson RS. Interdependence of hypoxic and innate immune responses. Nat Rev Immunol 2009;9:609-17.
20. Xiao J, Palefsky JM, Herrera R, Berline J, Tugizov SM. The Epstein-Barr virus BMRF-2 protein facilitates virus attachment to oral epithelial cells. Virology 2008;370:430-42.
21. Xiao J, Palefsky JM, Herrera R, Tugizov SM. Characterization of the Epstein-Barr virus glycoprotein BMRF-2. Virology 2007;359:382-96.
22. de Visser KE, Coussens LM. The inflammatory tumor microenvironment and its impact on cancer development. Contrib Microbiol 2006;13:118-37.
23. Xu J, Menezes J, Prasad U, Ahmad A. Elevated serum levels of transforming growth factor beta1 in Epstein-Barr virus-associated nasopharyngeal carcinoma patients. Int J Cancer 1999;84:396-9.
24. Xu J, Ahmad A, Jones JF, Dolcetti R, Vaccher E, Prasad U, Menezes J. Elevated serum transforming growth factor beta1 levels in Epstein-Barr virus-associated diseases and their correlation with virus-specific immunoglobulin A (IgA) and IgM. J Virol 2000;74:2443-6.
25. Gruhne B, Sompallae R, Marescotti D, Kamranvar SA, Gastaldello S, Masucci MG. The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species. Proc Natl Acad Sci USA 2009;106:2091-2092.
26. Man C, Rosa J, Lee LT, Lee VH, Chow BK, Lo KW, Doxsey S, Wu ZG, Kwong YL, Jin DY, Cheung AL, Tsao SW. Latent membrane protein 1 suppresses RASSF1A expression, disrupts microtubule structures and induces chromosomal aberrations in human epithelial cells. Oncogene 2007;26:3069-80.
27. Saridakis V, Sheng Y, Sarkari F, Holowaty MN, Shire K, Nguyen T, Zhang RG, Liao J, Lee W, Edwards AM, Arrowsmith CH, Frappier L. Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization. Mol Cell 2005;18:25-36.
28. Sivachandran N, Sarkari F, Frappier L. Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies. PLoS Pathog 2008;4:e1000170.
29. Roca H, Varsos Z, Pienta KJ. CCL2 protects prostate cancer PC3 cells from autophagic death via phosphatidylinositol 3-kinase/AKT-dependent survivin up-regulation. J Biol Chem 2008;283:25057-73.
30. Buettner M, Meyer B, Schreck S, Niedobitek G. Expression of RANTES and MCP-1 in epithelial cells is regulated via LMP1 and CD40. Int J Cancer 2007;121:2703-10. (Pubitemid 350136415)
31. Loukinova E, Dong G, Enamorado-Ayalya I, Thomas GR, Chen Z, Schreiber H, Van Waes C. Growth regulated oncogene-alpha expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC receptor-2 dependent mechanism. Oncogene 2000;19:3477-86.